Chicago Partners Investment Group LLC Gilead Sciences, Inc. Transaction History
Chicago Partners Investment Group LLC
- $2.81 Billion
- Q4 2024
A detailed history of Chicago Partners Investment Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 7,129 shares of GILD stock, worth $698,570. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,129
Previous 6,850
4.07%
Holding current value
$698,570
Previous $574,000
14.63%
% of portfolio
0.02%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
1,968Shares Held
996MCall Options Held
10.5MPut Options Held
9.85M-
Black Rock Inc. New York, NY121MShares$11.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.3 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.5 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$6.06 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.9 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $123B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...